ConductScience.org, home

Paper15375111

Combinations of antifungal agents in therapy--what value are they?

Cuenca-Estrella M. J Antimicrob Chemother, 2004. Cited by 120 papers, by iCite.

Cite this record

ConductScience Library. Combinations of antifungal agents in therapy--what value are they? Papers, record 15375111. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/15375111

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Combinations of antifungal agents in therapy--what value are they?
PubMed
Journal
J Antimicrob Chemother
PubMed
Year
2004
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
120
iCite
Relative citation ratio, by iCite
3.91
iCite
Revised in PubMed
2018-12-01
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cuenca-Estrella MManuel

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antifungal AgentsMajor topic
MycosesMajor topic
Amphotericin B
Animals
Azoles
Caspofungin
Drug Therapy, Combination
Echinocandins
Flucytosine
Humans
Lipopeptides
Microbial Sensitivity Tests
Naphthalenes
Peptides, Cyclic
Terbinafine

Source PubMed

Download CSV of topics

Cited by58

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 120 citations.

PMIDTitleJournalYearIn PapersSource
42655000Synergic Effect of Fluconazole and Quinoline Derivatives Combination Against Cryptococcus spp., Mechanisms of Action and Toxicity.Microorganisms2026https://conductscience.org/library/papers/42655000PubMed
42480284Brazilian guidelines for the diagnosis and treatment of candidemia and invasive candidiasis in adults and children.Braz J Infect Dis2026https://conductscience.org/library/papers/42480284PubMed
41858679A review of the current anti-Cryptococcus antifungals and emerging treatment strategies.New Microbes New Infect2026https://conductscience.org/library/papers/41858679PubMed
41033079Design, synthesis and SAR studies of N'-(Ethynylsalicylidene)arenecarbohydrazides as next-generation broad-spectrum antifungal agents.Bioorg Med Chem2025https://conductscience.org/library/papers/41033079PubMed
40589578Rhein restores the sensitivity of mcr-1 carrying multidrug-resistant Escherichia coli to colistin.Front Microbiol2025https://conductscience.org/library/papers/40589578PubMed
39897698The evolution of antifungal therapy: Traditional agents, current challenges and future perspectives.Curr Res Microb Sci2025https://conductscience.org/library/papers/39897698PubMed
39863777
Therapeutic alternatives for sporotrichosis induced by wild-type and non-wild-type Sporothrix schenckii through in vitro and in vivo assessment of enilconazole, isavuconazole, posaconazole, and terbinafine.
Sci Rep2025https://conductscience.org/library/papers/39863777PubMed
39831789The fluoroquinolone compounds potentiate the antifungal activity of the echinocandins against Aspergillus fumigatus.Biosci Rep2025https://conductscience.org/library/papers/39831789PubMed
39528542Diverse antifungal potency of terbinafine as a therapeutic agent against Exophiala dermatitidis in vitro.Sci Rep2024https://conductscience.org/library/papers/39528542PubMed
38549526Gallic Acid Derived 1, 2-Diarylindole as a Potential Synergistic Antifungal Agent against Candida Strains.Curr Top Med Chem2025https://conductscience.org/library/papers/38549526PubMed
38341568The anti-staphylococcal fusidic acid as an efflux pump inhibitor combined with fluconazole against vaginal candidiasis in mouse model.BMC Microbiol2024https://conductscience.org/library/papers/38341568PubMed
38099117Therapeutic Updates on the Management of Tinea Corporis or Cruris in the Era of Trichophyton Indotineae: Separating Evidence from Hype-A Narrative Review.Indian J Dermatol2023https://conductscience.org/library/papers/38099117PubMed
37995041Synthesis and antifungal evaluation against Candida spp. of the (E)-3-(furan-2-yl)acrylic acid.Braz J Microbiol2024https://conductscience.org/library/papers/37995041PubMed
37447064The Chemical Profile, and Antidermatophytic, Anti-Inflammatory, Antioxidant and Antitumor Activities of Withania chevalieri A.E. Gonç. Ethanolic Extract.Plants (Basel)2023https://conductscience.org/library/papers/37447064PubMed
36603818Diagnosis and Treatment of Invasive Mold Diseases.Infect Chemother2023https://conductscience.org/library/papers/36603818PubMed
36506532Appraisal of selected ethnomedicinal plants as alternative therapies against onychomycosis: Evaluation of synergy and time-kill kinetics.Front Pharmacol2022https://conductscience.org/library/papers/36506532PubMed
34834886Honokiol and Magnolol: Insights into Their Antidermatophytic Effects.Plants (Basel)2021https://conductscience.org/library/papers/34834886PubMed
33972882Factorial design-assisted reversed phase-high performance liquid chromatography method for simultaneous determination of fluconazole, itraconazole and terbinafine.R Soc Open Sci2021https://conductscience.org/library/papers/33972882PubMed
33551624The antimicrobial and antibiofilm properties of allicin against Candida albicans and Staphylococcus aureus - A therapeutic potential for denture stomatitis.Saudi Dent J2021https://conductscience.org/library/papers/33551624PubMed
33228010Overview of Antifungal Drugs against Paracoccidioidomycosis: How Do We Start, Where Are We, and Where Are We Going?J Fungi (Basel)2020https://conductscience.org/library/papers/33228010PubMed

See all 58 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/15375111

GET https://conductscience.org/api/papers/v1/15375111/cited_by?page=2